Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Quilter core net inflows 'strong' during Q1

(Sharecast News) - Wealth management firm Quilter said on Wednesday that core net inflows were "strong" in Q1, continuing the momentum seen in late FY24. Quilter said Q1 core net inflows had surged 181% year-on-year to £2.27bn in the three months ended 31 March, while assets under management and administration were broadly unchanged year-on-year at £119.4bn.

In the FTSE 250-listed firm's high net worth segment, net inflows were up £16.0m at £119.0m, while Quilter's affluent segment said a 42% year-on-year increase in gross inflows to £4.19bn and a decrease in outflows.

However, Quilter did note that the outlook for market levels and interest rates was more uncertain than it had been at the time of its FY results just over a month ago, and stated that AuMA was estimated to be around 3% below the quarter-end level which, if sustained, would provide a headwind to 2025 revenues and profitability.

Chief executive Steven Levin said: "We have successfully managed our business through previous periods of market turbulence. Our advisers and investment managers remain highly engaged with our clients, and it is during volatile markets that the value of financial advice becomes most apparent.

"The assets we manage are largely long-term focused and, with the majority of our new business arising from asset consolidation, early second quarter indications point to a degree of resilience in flows. The structural growth opportunity in the UK wealth market remains and we continue to focus on our strategic initiatives and efficiency programmes. We remain confident that Quilter is well placed to navigate these uncertain macro challenges."

As of 0905 BST, Quilter shares were up 1.14% at 133.41p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.